JEOL Ltd
TSE:6951

Watchlist Manager
JEOL Ltd Logo
JEOL Ltd
TSE:6951
Watchlist
Price: 5 600 JPY 1.87% Market Closed
Market Cap: 286.2B JPY
Have any thoughts about
JEOL Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
JEOL Ltd

Revenue
192.9B JPY
Cost of Revenue
-103.5B JPY
Gross Profit
89.3B JPY
Operating Expenses
-54.3B JPY
Operating Income
35.1B JPY
Other Expenses
-10B JPY
Net Income
25.1B JPY

Margins Comparison
JEOL Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
JEOL Ltd
TSE:6951
286.4B JPY
46%
18%
13%
US
Abbott Laboratories
NYSE:ABT
198.3B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
67%
26%
29%
US
Stryker Corp
NYSE:SYK
139.7B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
132.4B USD
69%
18%
11%
IE
Medtronic PLC
NYSE:MDT
104.4B USD
65%
19%
13%
US
Becton Dickinson and Co
NYSE:BDX
65.5B USD
45%
14%
9%
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR
38%
12%
8%
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD
79%
28%
74%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
307.7B CNY
64%
36%
33%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD
41%
13%
9%
Country JP
Market Cap 286.4B JPY
Gross Margin
46%
Operating Margin
18%
Net Margin
13%
Country US
Market Cap 198.3B USD
Gross Margin
56%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 187.8B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
29%
Country US
Market Cap 139.7B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 132.4B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
11%
Country IE
Market Cap 104.4B USD
Gross Margin
65%
Operating Margin
19%
Net Margin
13%
Country US
Market Cap 65.5B USD
Gross Margin
45%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 44.1B USD
Gross Margin
79%
Operating Margin
28%
Net Margin
74%
Country CN
Market Cap 307.7B CNY
Gross Margin
64%
Operating Margin
36%
Net Margin
33%
Country US
Market Cap 36.2B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
JEOL Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
JEOL Ltd
TSE:6951
286.4B JPY
21%
12%
26%
17%
US
Abbott Laboratories
NYSE:ABT
198.3B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
139.7B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
132.4B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
104.4B USD
9%
5%
8%
7%
US
Becton Dickinson and Co
NYSE:BDX
65.5B USD
7%
3%
6%
5%
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR
11%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD
51%
37%
16%
18%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
307.7B CNY
33%
22%
30%
37%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD
22%
5%
10%
7%
Country JP
Market Cap 286.4B JPY
ROE
21%
ROA
12%
ROCE
26%
ROIC
17%
Country US
Market Cap 198.3B USD
ROE
15%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 187.8B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 139.7B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 132.4B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 104.4B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
7%
Country US
Market Cap 65.5B USD
ROE
7%
ROA
3%
ROCE
6%
ROIC
5%
Country DE
Market Cap 58.1B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 44.1B USD
ROE
51%
ROA
37%
ROCE
16%
ROIC
18%
Country CN
Market Cap 307.7B CNY
ROE
33%
ROA
22%
ROCE
30%
ROIC
37%
Country US
Market Cap 36.2B USD
ROE
22%
ROA
5%
ROCE
10%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top